Literature DB >> 17207858

Eosinophilic pneumonia induced by daptomycin.

Don Hayes1, Michael I Anstead, Robert J Kuhn.   

Abstract

We present a case of drug-induced eosinophilic pneumonia resulting from intravenous daptomycin being used as therapy for recurrent methicillin-sensitive Staphlococcus aureus endocarditis. The patient developed hypoxic respiratory failure requiring intubation and mechanical ventilation. Daptomycin therapy was discontinued immediately, and the patient improved significantly after the administration of intravenous corticosteroids allowing for extubation 3 days later.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17207858     DOI： 10.1016/j.jinf.2006.11.006

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


  16 in total

Review 1.  Eosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system reports.

Authors:  Peter W Kim; Alfred F Sorbello; Ronald T Wassel; Tracy M Pham; Joseph M Tonning; Sumathi Nambiar
Journal:  Drug Saf       Date:  2012-06-01       Impact factor: 5.606

Review 2.  Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci.

Authors:  Ana Maria Rivera; Helen W Boucher
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

3.  A rare cause of pulmonary infiltrates one should be aware of: a case of daptomycin-induced acute eosinophilic pneumonia.

Authors:  C Rether; A Conen; M Grossenbacher; W C Albrich
Journal:  Infection       Date:  2011-06-30       Impact factor: 3.553

4.  Blood culture-negative prosthetic valve endocarditis and daptomycin-associated eosinophilic pneumonia: A case report.

Authors:  Emi Fujii; Takuto Arita; Tokuhisa Uejima; Minoru Matsuhama; Mitsuru Iida; Tatsuya Inoue; Junji Yajima; Takeshi Yamashita
Journal:  J Cardiol Cases       Date:  2022-02-20

Review 5.  Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia.

Authors:  Philip I Hair; Susan J Keam
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  Eosinophilic pneumonia associated with daptomycin: a case report and a review of the literature.

Authors:  Andreas S Kalogeropoulos; Sotirios Tsiodras; Dionysios Loverdos; Panagiotis Fanourgiakis; Athanasios Skoutelis
Journal:  J Med Case Rep       Date:  2011-01-17

Review 7.  Daptomycin-induced eosinophilic pneumonia - a systematic review.

Authors:  Priyasha Uppal; Kerry L LaPlante; Melissa M Gaitanis; Matthew D Jankowich; Kristina E Ward
Journal:  Antimicrob Resist Infect Control       Date:  2016-12-12       Impact factor: 4.887

8.  Daptomycin-induced Eosinophilic Pneumonia and a Review of the Published Literature.

Authors:  Yoshitsugu Higashi; Shigeki Nakamura; Yasuhiro Tsuji; Chika Ogami; Kaoru Matsumoto; Koyomi Kawago; Kotaro Tokui; Ryuji Hayashi; Ippei Sakamaki; Yoshihiro Yamamoto
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

9.  Daptomycin-Induced Acute Eosinophilic Pneumonia: Late Onset and Quick Recovery.

Authors:  Mohamad Rachid; Khansa Ahmad; Meghan Saunders-Kurban; Aelia Fatima; Aditya Shah; Anas Nahhas
Journal:  Case Rep Pulmonol       Date:  2017-11-01

10.  Daptomycin eosinophilic pneumonia: an adverse effect to be aware of.

Authors:  G Abelenda Alonso; I Montes Rodríguez; J Martín Torres; P Del Valle Loarte
Journal:  Rev Esp Quimioter       Date:  2018-05-22       Impact factor: 1.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.